phase iii results for rucaparib in ovarian cancer
Published 6 years ago • 69 plays • Length 1:42Download video MP4
Download video MP3
Similar videos
-
1:21
rucaparib may improve pfs in patients with ovarian cancer
-
1:19
dr. ledermann on phase iii ariel3 results in ovarian cancer
-
4:20
rucaparib explored for high-risk ovarian cancer
-
3:04
phase ii results for niraparib in heavily pretreated patients with ovarian cancer
-
2:55
results of engot-ov16/nova phase iii trial of niraparib in platinum-sensitive ovarian cancer
-
4:25
rucaparib: clinical activity in relapsed ovarian cancer
-
2:39
nova phase iii trial of niraparib in platinum-sensitive ovarian cancer patients
-
1:13
comparison of trials of niraparib, olaparib and rucaparib in ovarian cancer
-
5:11
defining rucaparib’s value in recurrent ovarian cancer
-
2:58
rucaparib for relapsed ovarian cancer: safety profile
-
3:11
rucaparib in recurrent ovarian cancer: ariel3 trial
-
2:07
rucaparib in platinum-sensitive ovarian cancer
-
6:12
rucaparib for recurrent ovarian cancer
-
2:11
design of the nova trial for ovarian cancer
-
3:06
rucaparib maintenance therapy for high-risk ovarian cancer
-
2:25
results of niraparib/bevacizumab combo in platinum-sensitive recurrent ovarian cancer
-
2:15
toxicities associated with rucaparib for the treatment of ovarian cancer
-
1:48
niraparib maintenance therapy in ovarian cancer
-
1:12
data demonstrate efficacy of 3 parp inhibitors in ovarian cancer